252 related articles for article (PubMed ID: 32929678)
1. The Combined Use of SBRT and Immunotherapy-a Literature Review.
Lubas MJ; Kumar SS
Curr Oncol Rep; 2020 Sep; 22(12):117. PubMed ID: 32929678
[TBL] [Abstract][Full Text] [Related]
2. SBRT combined with PD-1/PD-L1 inhibitors in NSCLC treatment: a focus on the mechanisms, advances, and future challenges.
Chen Y; Gao M; Huang Z; Yu J; Meng X
J Hematol Oncol; 2020 Jul; 13(1):105. PubMed ID: 32723363
[TBL] [Abstract][Full Text] [Related]
3. The dynamic duo: A narrative review on the synergy between stereotactic body radiotherapy and immunotherapy in lung cancer treatment (Review).
Cheng SH; Tu KY; Lee HH
Oncol Rep; 2024 Jul; 52(1):. PubMed ID: 38874014
[TBL] [Abstract][Full Text] [Related]
4. Neoadjuvant SBRT combined with immunotherapy in NSCLC: from mechanisms to therapy.
Shi Y; Ma X; He D; Dong B; Qiao T
Front Immunol; 2023; 14():1213222. PubMed ID: 37600799
[TBL] [Abstract][Full Text] [Related]
5. A Prospective Trial Evaluating the Safety and Systemic Response From the Concurrent Use of Radiation Therapy with Checkpoint Inhibitor Immunotherapy in Metastatic Non-Small Cell Lung Cancer.
Mattes MD; Eubank TD; Almubarak M; Wen S; Marano GD; Jacobson GM; Ma PC
Clin Lung Cancer; 2021 Jul; 22(4):268-273. PubMed ID: 33608212
[TBL] [Abstract][Full Text] [Related]
6. Immune Checkpoints Inhibitors and SRS/SBRT Synergy in Metastatic Non-Small-Cell Lung Cancer and Melanoma: A Systematic Review.
Rodríguez Plá M; Dualde Beltrán D; Ferrer Albiach E
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769050
[No Abstract] [Full Text] [Related]
7. Radiation and immunotherapy combinations in non-small cell lung cancer.
Azghadi S; Daly ME
Cancer Treat Res Commun; 2021; 26():100298. PubMed ID: 33387868
[TBL] [Abstract][Full Text] [Related]
8. Radiotherapy and Immunotherapy Combinations for Lung Cancer.
Agrawal V; Benjamin KT; Ko EC
Curr Oncol Rep; 2020 Nov; 23(1):4. PubMed ID: 33215306
[TBL] [Abstract][Full Text] [Related]
9. Stereotactic Ablative Radiotherapy Combined with Immune Checkpoint Inhibitors Reboots the Immune Response Assisted by Immunotherapy in Metastatic Lung Cancer: A Systematic Review.
Chicas-Sett R; Morales-Orue I; Castilla-Martinez J; Zafra-Martin J; Kannemann A; Blanco J; Lloret M; Lara PC
Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31052488
[No Abstract] [Full Text] [Related]
10. [Treatment of non-small cell lung cancer].
Hopstaken JS; de Ruiter JC; van Diessen JNA; Theelen WSME; Monkhorst K; Hartemink KJ
Ned Tijdschr Geneeskd; 2021 Feb; 165():. PubMed ID: 33651512
[TBL] [Abstract][Full Text] [Related]
11. Safety and Efficacy of PD-1/PD-L1 inhibitors combined with radiotherapy in patients with non-small-cell lung cancer: a systematic review and meta-analysis.
Geng Y; Zhang Q; Feng S; Li C; Wang L; Zhao X; Yang Z; Li Z; Luo H; Liu R; Lu B; Wang X
Cancer Med; 2021 Feb; 10(4):1222-1239. PubMed ID: 33465302
[TBL] [Abstract][Full Text] [Related]
12. A Novel Neoadjuvant Therapy for Operable Locally Invasive Non-Small-Cell Lung Cancer. Phase I Study of Neoadjuvant Stereotactic Body Radiotherapy. LINNEARRE I (NCT02433574).
Nguyen NA; Isfahanian N; Pond G; Hanna W; Cutz JC; Wright J; Swaminath A; Shargall Y; Chow T; Wierzbicki M; Okawara G; Quan K; Finley C; Juergens R; Tsakiridis T
Clin Lung Cancer; 2017 Jul; 18(4):436-440.e1. PubMed ID: 28215851
[TBL] [Abstract][Full Text] [Related]
13. Combining Immunotherapy with Radiation Therapy in Non-Small Cell Lung Cancer.
Fitzgerald K; Simone CB
Thorac Surg Clin; 2020 May; 30(2):221-239. PubMed ID: 32327181
[TBL] [Abstract][Full Text] [Related]
14. Lung Stereotactic Body Radiation Therapy and Concurrent Immunotherapy: A Multicenter Safety and Toxicity Analysis.
Tian S; Switchenko JM; Buchwald ZS; Patel PR; Shelton JW; Kahn SE; Pillai RN; Steuer CE; Owonikoko TK; Behera M; Curran WJ; Higgins KA
Int J Radiat Oncol Biol Phys; 2020 Sep; 108(1):304-313. PubMed ID: 31982496
[TBL] [Abstract][Full Text] [Related]
15. Stereotactic body radiation therapy for early-stage non-small cell lung cancer: Executive Summary of an ASTRO Evidence-Based Guideline.
Videtic GMM; Donington J; Giuliani M; Heinzerling J; Karas TZ; Kelsey CR; Lally BE; Latzka K; Lo SS; Moghanaki D; Movsas B; Rimner A; Roach M; Rodrigues G; Shirvani SM; Simone CB; Timmerman R; Daly ME
Pract Radiat Oncol; 2017; 7(5):295-301. PubMed ID: 28596092
[TBL] [Abstract][Full Text] [Related]
16. Stereotatic radiotherapy in metastatic non-small cell lung cancer: Combining immunotherapy and radiotherapy with a focus on liver metastases.
Corrao G; Marvaso G; Ferrara R; Lo Russo G; Gugliandolo SG; Piperno G; Spaggiari L; De Marinis F; Orecchia R; Garassino MC; Jereczek-Fossa BA
Lung Cancer; 2020 Apr; 142():70-79. PubMed ID: 32120227
[TBL] [Abstract][Full Text] [Related]
17. Checkpoint inhibition in combination with an immunoboost of external beam radiotherapy in solid tumors (CHEERS): study protocol for a phase 2, open-label, randomized controlled trial.
Spaas M; Sundahl N; Hulstaert E; Kruse V; Rottey S; De Maeseneer D; Surmont V; Meireson A; Brochez L; Reynders D; Goetghebeur E; Van den Begin R; Van Gestel D; Renard V; Dirix P; Mestdagh P; Ost P
BMC Cancer; 2021 May; 21(1):514. PubMed ID: 33962592
[TBL] [Abstract][Full Text] [Related]
18. Moving Immunotherapy Into the Treatment of Resectable Non-Small Cell Lung Cancer.
Chaft JE; Dziadziuszko R; Haddock Lobo Goulart B
Am Soc Clin Oncol Educ Book; 2024 Jun; 44(3):e432500. PubMed ID: 38788177
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of extracranial stereotactic body radiation therapy (SBRT) added to standard treatment in patients with solid tumors (breast, prostate and non-small cell lung cancer) with up to 3 bone-only metastases: study protocol for a randomised phase III trial (STEREO-OS).
Thureau S; Marchesi V; Vieillard MH; Perrier L; Lisbona A; Leheurteur M; Tredaniel J; Culine S; Dubray B; Bonnet N; Asselain B; Salleron J; Faivre JC
BMC Cancer; 2021 Feb; 21(1):117. PubMed ID: 33541288
[TBL] [Abstract][Full Text] [Related]
20. Immune modulation by hypofractionated stereotactic radiation therapy: Therapeutic implications.
Popp I; Grosu AL; Niedermann G; Duda DG
Radiother Oncol; 2016 Aug; 120(2):185-94. PubMed ID: 27495145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
